Controlled Human Malaria Infection in Semi-Immune Kenyan Adults. (CHMI-SIKA)

计划入组 200 人 · 首次发布于 2016 年 4 月 15 日

SIKAMIC (SIklos on Kidney Function and AlbuMInuria Clinical Trial)

计划入组 86 人 · 首次发布于 2019 年 1 月 16 日

Effects of High Intensity Circuit Training on Physical Fitness, Body Fat Percentage and Waist-Hip Ratio Among Sedentary Females of Sikandarabad

计划入组 60 人 · 首次发布于 2020 年 12 月 4 日

ChimeriVax-Zika

Sira-55

Zika(Biotron)

SIGA Technologies

India

MIKA Pharma GmbH

Germany

SIGA TECHNOLOGIES, INC.

United States

Coca-Cola Faces Antitrust Scrutiny in COMESA and Kenya

Cellectar to Present New Phase 2 Data on Iopofosine I 131 for Waldenstrom’s Macroglobulinemia at ASH 2024

Iopofosine I 131 Shows Promise in Heavily Pretreated Waldenström Macroglobulinemia